Fordham 32 (Report 1): Patents in Pharma By Annsley Merelle Ward on Thursday, April 24, 2025 AmeriKat Bolar exemption CJEU referral fordham 2025 IPKat national law pharma Second medical use SPC upc +
[UPDATE] IPKat/LSE Joint Event: The CJEU's billion-dollar questions - who gets a SEP licence and when should an injunction be granted? By Annsley Merelle Ward on Thursday, April 15, 2021 #IPKat abuse of a dominant position Article 102 CJEU CJEU referral competition law component dusseldorf end-product events handset Injunction IPKat event LSE Nokia v Daimler patent licensing SEP/FRAND +
IPKat/LSE Joint Event: The CJEU's billion-dollar questions - who gets a SEP licence and when should an injunction be granted? By Annsley Merelle Ward on Thursday, April 01, 2021 #IPKat abuse of a dominant position Article 102 CJEU CJEU referral competition law component dusseldorf end-product events handset Injunction IPKat event LSE Nokia v Daimler patent licensing SEP/FRAND +
Article 3(a) just keeps on giving: AG Opinion in SPC referrals C-650/17 and C-114/18 By Dr Rose Hughes on Friday, September 13, 2019 article 3(a) C-650/17 C‑114/18 CJEU referral patents Regulation (EC) No. 469/2009 Rose Hughes sitgliptin SPC Truvada +